Bio Techne Corp Stock Investor Sentiment

TECH Stock  USD 62.58  0.42  0.68%   
Under 57% of Bio Techne's investor base is looking to short. The analysis of overall sentiment of trading Bio Techne Corp stock suggests that many investors are alarmed at this time. Bio Techne's investing sentiment shows overall attitude of investors towards Bio Techne Corp.

Comfort Level 43

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Bio Techne's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Bio Techne Corp.

Bio Historical Sentiment

Although Bio Techne's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Bio, such as negative comments on social media and news outlets, may cause fear in the market and push Bio Techne's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Bio.
  

Bio Techne Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Bio Techne can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Bio Techne Corp Historical Investor Sentiment

Investor biases related to Bio Techne's public news can be used to forecast risks associated with an investment in Bio. The trend in average sentiment can be used to explain how an investor holding Bio can time the market purely based on public headlines and social activities around Bio Techne Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Bio Techne's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bio Techne and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Bio Techne news discussions. The higher the estimate score, the more favorable the investor's outlook on Bio Techne.
a minute ago at finance.yahoo.com         
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
Yahoo News
a day ago at finance.yahoo.com         
Bio-Techne shareholders have earned a 8.3 percent CAGR over the last five years
Yahoo News
few days ago at aol.com         
Key Farage ally suggests Reform UK leader could replace party chair after chaotic week for party
news
few days ago at thelincolnianonline.com         
Bio-Techne Sets New 12-Month Low Time to Sell?
news
few days ago at finance.yahoo.com         
Q4 Earnings Highlights Sotera Health Company Vs The Rest Of The Research Tools Consumables Stocks
Yahoo News
few days ago at finance.yahoo.com         
Acquisition by William Geist of 7869 shares of Bio Techne subject to Rule 16b-3
Yahoo News
six days ago at thelincolnianonline.com         
Bio-Techne Lowered to Hold Rating by StockNews.com
news
over a week ago at finance.yahoo.com         
Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System
Yahoo News
over a week ago at thelincolnianonline.com         
Bio-Techne Co. Shares Bought by State of Michigan Retirement System
news
over a week ago at thelincolnianonline.com         
Dorsey Whitney Trust CO LLC Reduces Position in Bio-Techne Co.
news
over a week ago at finance.yahoo.com         
Techne Down 15.5 percent Since Last Earnings Report Can It Rebound?
Yahoo News
over a week ago at zacks.com         
Techne Down 15.5 percent Since Last Earnings Report Can It Rebound?
zacks News
over a week ago at independent.co.uk         
Reforms surge in polls grinds to a halt as Farage faces party rift over messianic leadership style
news
over a week ago at aol.com         
Reforms surge in polls grinds to a halt as Farage faces party rift over messianic leadership style
news
over a week ago at kalkinemedia.com         
How Bio-Technes Financial Health Supports Its Market Position
news
Far too much social signal, news, headlines, and media speculation about Bio Techne that are available to investors today. That information is available publicly through Bio media outlets and privately through word of mouth or via Bio internal channels. However, regardless of the origin, that massive amount of Bio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bio Techne news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bio Techne relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bio Techne's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bio Techne alpha.

Bio Techne Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Fort Washington Investment Advisors Inc. OH Boosts Holdings in Bio-Techne Co.
01/23/2025
2
Disposition of 13392 shares by Kim Kelderman of Bio Techne at 37.7 subject to Rule 16b-3
01/27/2025
3
Acquisition by Herr Amy E. of 115 shares of Bio Techne subject to Rule 16b-3
02/03/2025
4
Bio-Techne Shares Gap Down Whats Next
02/12/2025
5
Disposition of 1976 shares by Herr Amy E. of Bio Techne at 44.33 subject to Rule 16b-3
02/14/2025
6
Bio-Techne shareholders have endured a 37 percent loss from investing in the stock three years ago
02/24/2025
7
Fjarde AP Fonden Fourth Swedish National Pension Fund Sells 5,600 Shares of Bio-Techne Co.
02/27/2025
 
Bio Techne dividend paid on 28th of February 2025
02/28/2025
9
Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
03/03/2025
10
Reforms surge in polls grinds to a halt as Farage faces party rift over messianic leadership style
03/06/2025
11
Techne Down 15.5 percent Since Last Earnings Report Can It Rebound
03/07/2025
12
Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System
03/10/2025
13
Q4 Earnings Highlights Sotera Health Company Vs The Rest Of The Research Tools Consumables Stocks
03/12/2025

Complementary Tools for Bio Stock analysis

When running Bio Techne's price analysis, check to measure Bio Techne's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Techne is operating at the current time. Most of Bio Techne's value examination focuses on studying past and present price action to predict the probability of Bio Techne's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Techne's price. Additionally, you may evaluate how the addition of Bio Techne to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Global Correlations
Find global opportunities by holding instruments from different markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges